Диссертация (1140928), страница 15
Текст из файла (страница 15)
An introduction to ROC analysis //Pattern Recognition Letters.- 2006.–Vol.27.-P. 861—874.49. Fiedler M., Muller-Holzner E., Viertler H.P. et al. (2004) High level HPV-16 E7oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.FASEB J, 18(10), 1120-1122.2650.
Garraway IP, Sun W, Tran CP, et al. Human prostate sphereforming cells represent asubset of basal epithelial cells capable of glandular regeneration in vivo. Prostate2010; 70: 491-501.51. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal andmalignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell 2007;1:555–567.52.
Girardi F, Burghardt E, Pickel H. Small FIGO stage IB cervical cancer[J].Gynecologic oncology, 1994, 55(3): 427-432.53. Guan P, Howell‐Jones R, Li N, et al. Human papillomavirus types in 115,789 HPV‐ positive women: A meta ‐ analysis from cervical infection to cancer[J].International Journal of Cancer, 2012, 131(10): 2349-2359.54. Hermann PC, Huber SL, Herrler T, et al. Distinct Populations of Cancer Stem CellsDetermine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer.
CellStem Cell 2007; 1: 313-23.12955. Hibi K, Takahashi T, Sekido Y, et al. Coexpression of the stem cell factor and the c-kitgenes in small-cell lung cancer[J]. Oncogene, 1991, 6(12): 2291-2296.56. Ho G Y F, Burk R D, Klein S, et al. Persistent genital human papillomavirusinfection as a risk factor for persistent cervical dysplasia[J]. Journal of the NationalCancer Institute, 1995, 87(18): 1365-1371.57. Ho GY, Bierman R, Beardsley I, Chang CJ, Burk RD. Natural history ofcervicovaginal papillomavirus infection in young women.
The New England journalof medicine 1998;338:123-128.58. Hong-Wu Xin et al.: Tumor-Initiating Label-Retaining Cancer Cells in HumanGastrointestinal Cancers Undergo Asymmetric Cell Division, STEM CELLS, 30:591–598. doi: 10.1002/stem.1061, 22 MAR 2012.59. Jacobs M V, Snijders P J, Voorhorst F J, et al. Reliable high risk HPV DNA testingby polymerase chain reaction: an intermethod and intramethod comparison[J].Journal of clinical pathology, 1999, 52(7): 498-503.60.
Jaume O, Amaia S, Meritxell M. Usefulness of p16/ki76 immunostaining in thetriage of women referred to colposcopy. Cancer Cytopathology. 2014;122:227-35.61. Jones D L, Wagers A J. No place like home: anatomy and function of the stem cellniche[J]. Nature Reviews Molecular Cell Biology, 2008, 9(1): 11-21.62. Kim M S, Bak Y, Park Y S, et al. Wogonin induces apoptosis by suppressing E6 andE7 expressions and activating intrinsic signaling pathways in HPV-16 cervicalcancer cells[J]. Cell biology and toxicology, 2013, 29(4): 259-272.13063. Kim M.-J., Kim J.J., Kim S.Type-specific prevalence of high-risk humanpapillomavirus by cervical cytology and age: Data from the health check-ups of 7,014Korean women // Obstet Gynecol Sci.-2013.-Vol.56.-N2.-P.110-120.64.
Kjellberg L, Hallmans G, Åhren A M, et al. Smoking, diet, pregnancy and oralcontraceptive use as risk factors for cervical intra-epithelial neoplasia in relation tohuman papillomavirus infection[J]. British journal of cancer, 2000, 82(7): 1332.65. Kogan E A, Fayzullina N M, Demura T A, et al. Reparative Spheroids inHPV-Associated Chronic Cervicitis[J].66. Koskela P, Anttila T, Bjørge T, et al. Chlamydia trachomatis infection as a risk factorfor invasive cervical cancer[J]. International journal of cancer, 2000, 85(1): 35-39.67. Kurian E.M., Caporelli M.L., Baker S. et al.
Cervista HR and HPV 16/18 assays vsHybrid Capture 2 assay. Outcome comparison in women with negative cervicalcytology //Am J Clin Pathol.- 2011.-Vol.136.-P. 808-816.68. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloidleukaemia after transplantation into SCID mice. Nature 1994; 367: 645-48.69. Lee W Y, Huang S C, Hsu K F, et al. Roles for hypoxia-regulated genes duringcervical carcinogenesis: Somatic evolution during the hypoxia–glycolysis–acidosissequence[J]. Gynecologic oncology, 2008, 108(2): 377-384.70. Li C, Heidt DG, Dalerba P, et al. Identification of Pancreatic Cancer Stem Cells.Cancer Res 2007; 67: 1030-7.71. Li F. Tiede, B.Massaquu J., Kang Y. Beyond tumorogenesis: cancer stem cells inmetastasis//Cell Res.
– 2007. – Vol. 17. – P. 3-14.13172. Li L, Xie T. Stem cell niche: structure and function[J]. Annu. Rev. Cell Dev. Biol.,2005, 21: 605-631.73. Li, L. et al., Ubiquitination of MDM2 modulated by Epstein-Barr virus encodedlatent membrane protein1[J], VirusRes,2007, 5(13):1-6.74. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A.Cancer-initiating cells derived from established cervical cell lines exhibit stem-cellmarkers and increased radioresistance. BMC Cancer 2012; 12: 48.75. López J.
et al. Human papillomavirus infections and cancer stem cells of tumors fromthe uterine cervix //The open virology journal. – 2012. – Т. 6. – №. 1.76. Magni M, Shammah S, Schiro R et al. Induction of cyclophosphamide-resistance byaldehyde-dehydrogenase gene transfer. Blood 1996;87:1097–1103.77. Markowitz L E, Dunne E F, Saraiya M, et al. Human papillomavirus vaccination:recommendations of the Advisory Committee on Immunization Practices (ACIP)[J].MMWR Recomm Rep, 2014, 63(RR-05): 1-30.78. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME,Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ.
The tumour suppressor protein VHLtargets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.1999;399:271–5.79. Mesher D., Cuschieri K., Hibbitts S. et al. Type-specific HPV prevalence in invasivecervical cancer in the UK prior to national HPV immunisation programme: baselinefor monitoring the effects of immunization // J Clin Pathol.- 2015.-Vol.68,N2.P.135-140.13280. Miller D. M. et al.
c-Myc and cancer metabolism //Clinical Cancer Research. – 2012.– Т. 18. – №. 20. – С. 5546-5553.81. Morrison S J, Spradling A C. Stem cells and niches: mechanisms that promote stemcell maintenance throughout life[J]. Cell, 2008, 132(4): 598-611.;82. Moscicki A. CIN management guidelines in adolescents and young women.Abstracts the International papillomavirus society symposium. April 13-14. 2007.Warsaw. P.17.83.
No J H, Jo H, Kim S H, et al. Expression of Vascular Endothelial Growth Factorand Hypoxia Inducible Factor‐1α in Cervical Neoplasia[J]. Annals of the NewYork Academy of Sciences, 2009, 1171(1): 105-110.84. Nowell P. C. The clonal evolution of tumor cell populations //Science. – 1976. – Т.194. – №. 4260. – С. 23-28.85.
O’Brien C A, Pollett A, Gallinger S, et al. A human colon cancer cell capable ofinitiating tumour growth in immunodeficient mice[J]. Nature, 2007, 445(7123):106-110.86. O'Brien CA, Kreso A, Dick JE. Cancer stem cells in solid tumors: an overview.Semin Radiat Oncol 2009; 19: 71-7.87. Organista-Nava J., Gómez-Gómez Y., Gariglio P. Embryonic stem cell-specificsignature in cervical cancer //Tumor Biology.
– 2014. – Т. 35. – №. 3. – С. 1727-1738.88. Parkin D.M. Global cancer statistics, 2002/ D.M. Parkin, F. Bray, J. Ferlay,P.Pissini// CA Cancer J. Clin. - 2005.-V. 55 - P.74-108.13389. Petry K.U., Schmidt D., Scherbring S.et al. Triaging Pap cytology negative, HPVpositive cervical cancer screening results with p16/Ki-67 dual-stained cytology//Gynecol Oncol. – 2011.
– Vol. 121. – P.505–509.90. Pimenta J M, Galindo C, Jenkins D, et al. Estimate of the global burden of cervicaladenocarcinoma and potential impact of prophylactic human papillomavirusvaccination[J]. BMC cancer, 2013, 13(1): 1.91. Polyak K, Hahn W C. Roots and stems: stem cells in cancer[J]. Nature medicine,2006, 12(3): 296-300.92. Ponti D, Costa A, Zaffaroni N, et al. Isolation and In vitro Propagation ofTumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties. Cancer Res2005; 65: 5506-11.93. Prince ME, Sivanandan R, Kaczorowski A, et al.
Identification of a subpopulationof cells with cancer stem cell properties in head and neck squamous cell carcinoma.Proc Natl Acad Sci USA 2007; 104: 973-78.94. Ratnam S., Coutlee F., Fontaine D. et al. APTIMA HPV E6/E7 mRNA test is assensitive as Hybrid Capture 2 Assay but more specific at detecting cervicalprecancer and cancer // J Clin Microbiol.- 2011.-Vol. 49, N2.-P.557-564.95. Reiter R E, Gu Z, Watabe T, et al.
Prostate stem cell antigen: a cell surface markeroverexpressed in prostate cancer[J]. Proceedings of the National Academy ofSciences, 1998, 95(4): 1735-1740.13496. Reuschenbach M., Seiz M., von Knebel Doeberitz C. et al. Evaluation of cervicalcone biopsies for coexpression of p16INK4a and Ki67 in epithelial cells // Int JCancer. – 2012. - Vol.130, N 2.
– P.388-394.97. Reya T. et al. Stem cells, cancer, and cancer stem cells //nature. – 2001. – Т. 414. – №.6859. – С. 105-111.98. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells ofthe adult mammalian central nervous system. Science 1992; 255: 1707-10.99. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion ofhuman colon-cancer-initiating cells. Nature 2007; 445: 111-5.13.100.Richart R M. Cervical intraepithelial neoplasia[J]. Pathology annual, 1973, 8:301.101.Rijkaart D.C., Berkhof J., Rozendaal L. et al.
Human papillomavirus testing forthe detection of high-grade cervical intraepithelial neoplasia and cancer: final resultsof the POBASCAM randomised controlled trial // Lancet Oncol.- 2012.- Vol.13,N1.-P. 78-88.102.Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causescardiac dysfunction during pressure overload[J]. Nature, 2007, 446(7134): 444-448.103.Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating humanmelanomas. Nature 2008; 451: 345-49.104.Scheffner M, Huibregtse J M, Vierstra R D, et al. The HPV-16 E6 and E6-APcomplex functions as a ubiquitin-protein ligase in the ubiquitination of p53[J].
Cell,1993, 75(3): 495-505.135105.Schlessinger D., Van Zant G. Does functional depletion of stem cells drive aging?//Mechanisms of ageing and development. – 2001. – Т. 122. – №. 14. – С. 1537-1553.106.Schmidt D., Bergeron C., Denton K.J. et al. European CINtec Cytology StudyGroup (2011) p16/ki-67 dual-stain cytology in the triage of ASCUS and LSILPapanicolaou cytology: results from the European equivocal or mildly abnormalPapanicolaou cytology study// Cancer Cytopathol. – 2011. – Vol.
119. –P.158–166.107.Schneider V, Kay S, Lee H M. Immunosuppression as a high-risk factor in thedevelopment of condyloma acuminatum and squamous neoplasia of the cervix[J].Acta cytologica, 1982, 27(3): 220-224.108.Semenza G L. HIF-1 and tumor progression: pathophysiology andtherapeutics[J]. Trends in molecular medicine, 2002, 8(4): S62-S67.109.Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer.2003;3:721–32.110.Singh G K, Miller B A, Hankey B F, et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
